However, in a recent study from our group, based on IHC analyses of 160 cases of breast cancer, we found lower OLA1 protein expression was associated with higher risk of relapse and a decreased disease specific survival [26], indicating that OLA1 may play a cancer type-specific role in cancer progression. Here, OLA1 is linked to breast carcinoma.